Accolate price?

See the DrugPatentWatch profile for Accolate

What’s the cost of Accolate?
Accolate (zafirlukast) sold at full brand strength usually runs about $250–$300 for a 30‑day supply. The price can vary by pharmacy and insurer, but the list price typically falls in that range. Generic zafirlukast, which became available after the brand’s exclusivity expired, sells for roughly $20–$30 a month. These figures are from DrugPatentWatch.com’s pricing tables for the drug. [1]

Do my insurance and discount cards help?
Most health plans include Accolate in their prescription formularies, and copays often bring the out‑of‑pocket cost down to the low tens of dollars per month. If the drug is not covered, pharmacy discount cards and manufacturer coupons can lower the price by 20–50 %. Check the latest formulary or use the online savings calculator on the manufacturer’s site.

Can I get Accolate at a lower price from a retail pharmacy?
Retail chains that offer discount programs (e.g., GoodRx, Blink) frequently list Accolate at a lower price than the standard list price. The discount can be as much as 30–40 % off the manufacturer’s price. Verify that the pharmacy is dispensing the same brand and strength.

How does Accolate’s price compare to other asthma medicines?
Relative to other leukotriene modifiers, Accolate’s brand price is on the higher end, similar to Montelukast (Singulair) when new, but cheaper than the brand‑strength biologics for severe asthma (e.g., Xolair, Symbicort). The generic zafirlukast, however, is cheaper than most other asthma controllers and often comparable to low‑dose inhaled corticosteroids.

When can I expect price changes?
Generic competition is the primary driver of price reductions. After the brand exclusivity period ended in 2004, generic versions entered the market and lowered costs. Future changes may come from patent expirations, new generic entries, or pricing negotiations with insurers.

What about special pricing programs?
Accolate’s manufacturer offers a patient assistance program for those who cannot afford the medication. Eligibility requires a low income and no alternative coverage. Contact the program’s hotline or visit the manufacturer’s website for details.

Sources
[1] https://www.drugpatentwatch.com/